doi	title	authors	title_name	year	downloads	visitors	countries
10.3324/haematol.2014.113381	Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol	N. Bolli, N. Manes, T. McKerrell, J. Chi, N. Park, G. Gundem, M. A. Quail, V. Sathiaseelan, B. Herman, C. Crawley, J. I. O. Craig, N. Conte, C. Grove, E. Papaemmanuil, P. J. Campbell, I. Varela, P. Costeas, G. S. Vassiliou	Haematologica	2014	9	9	5
10.3324/haematol.2013.098384	The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy	G. Packham, S. Krysov, A. Allen, N. Savelyeva, A. J. Steele, F. Forconi, F. K. Stevenson	Haematologica	2014	14	7	4
10.3324/haematol.2015.128793	Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience	P. Strati, S. H. Nasr, N. Leung, C. A. Hanson, K. G. Chaffee, S. M. Schwager, S. J. Achenbach, T. G. Call, S. A. Parikh, W. Ding, N. E. Kay, T. D. Shanafelt	Haematologica	2015	13	7	4
10.3324/haematol.2013.096107	Management of chronic lymphocytic leukemia	P. Ghia, M. Hallek	Haematologica	2014	12	6	3
10.3324/haematol.2014.112748	Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia	C. O'Hear, J. F. Heiber, I. Schubert, G. Fey, T. L. Geiger	Haematologica	2014	11	5	4
10.3324/haematol.2014.114827	 -thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapies	S. Rivella	Haematologica	2015	5	5	5
10.3324/haematol.2015.129221	Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia	G. Gugliotta, F. Castagnetti, M. Breccia, L. Levato, M. D'Adda, F. Stagno, M. Tiribelli, M. Salvucci, C. Fava, B. Martino, M. Cedrone, M. Bocchia, E. Trabacchi, F. Cavazzini, E. Usala, A. R. Rossi, M. T. Bochicchio, S. Soverini, G. Alimena, M. Cavo, F. Pane, G. Martinelli, G. Saglio, M. Baccarani, G. Rosti, None None	Haematologica	2015	5	5	2
10.3324/haematol.2013.098574	ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial	M. J. J. Rose-Zerilli, J. Forster, H. Parker, A. Parker, A. E. Rodriguez, T. Chaplin, A. Gardiner, A. J. Steele, A. Collins, B. D. Young, A. Skowronska, D. Catovsky, T. Stankovic, D. G. Oscier, J. C. Strefford	Haematologica	2014	11	4	1
10.3324/haematol.2013.099747	Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel	E. Angelucci, S. Matthes-Martin, D. Baronciani, F. Bernaudin, S. Bonanomi, M. D. Cappellini, J.-H. Dalle, P. Di Bartolomeo, C. D. de Heredia, R. Dickerhoff, C. Giardini, E. Gluckman, A. A. Hussein, N. Kamani, M. Minkov, F. Locatelli, V. Rocha, P. Sedlacek, F. Smiers, I. Thuret, I. Yaniv, M. Cavazzana, C. Peters, None None	Haematologica	2014	4	4	4
10.3324/haematol.2013.100818	R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes	J. F. Seymour, M. Pfreundschuh, M. Trneny, L. H. Sehn, J. Catalano, E. Csinady, N. Moore, B. Coiffier, None None	Haematologica	2014	4	4	2
10.3324/haematol.2014.104661	Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion	P. Strati, M. J. Keating, S. M. O'Brien, A. Ferrajoli, J. Burger, S. Faderl, F. P. Tambaro, N. Jain, W. G. Wierda	Haematologica	2014	11	4	2
10.3324/haematol.2014.109777	Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting	L.-A. Sutton, V. Ljungstrom, L. Mansouri, E. Young, D. Cortese, V. Navrkalova, J. Malcikova, A. F. Muggen, M. Trbusek, P. Panagiotidis, F. Davi, C. Belessi, A. W. Langerak, P. Ghia, S. Pospisilova, K. Stamatopoulos, R. Rosenquist	Haematologica	2014	9	4	2
10.3324/haematol.2014.111492	Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management	D. Rampton, J. Folkersen, S. Fishbane, M. Hedenus, S. Howaldt, F. Locatelli, S. Patni, J. Szebeni, G. Weiss	Haematologica	2014	4	4	3
10.3324/haematol.2014.114561	Treatment of autoimmune hemolytic anemias	A. Zanella, W. Barcellini	Haematologica	2014	5	4	3
10.3324/haematol.2014.118612	ANGPTL7 regulates the expansion and repopulation of human hematopoietic stem and progenitor cells	Y. Xiao, Z. Jiang, Y. Li, W. Ye, B. Jia, M. Zhang, Y. Xu, D. Wu, L. Lai, Y. Chen, Y. Chang, X. Huang, H. Liu, G. Qing, P. Liu, Y. Li, B. Xu, M. Zhong, Y. Yao, D. Pei, P. Li	Haematologica	2015	4	4	1
10.3324/haematol.2014.120238	Low frequency mutations independently predict poor treatment-free survival in early stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis	N. Winkelmann, M. Rose-Zerilli, J. Forster, M. Parry, A. Parker, A. Gardiner, Z. Davies, A. J. Steele, H. Parker, N. C. P. Cross, D. G. Oscier, J. C. Strefford	Haematologica	2015	11	4	1
10.3324/haematol.2013.087171	Targeting the phosphoinositide 3-kinase pathway in hematologic malignancies	E. Jabbour, O. G. Ottmann, M. Deininger, A. Hochhaus	Haematologica	2014	3	3	2
10.3324/haematol.2013.092007	Epigenetics in the hematologic malignancies	C. Y. Fong, J. Morison, M. A. Dawson	Haematologica	2014	3	3	2
10.3324/haematol.2013.096537	Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib	B. Hanfstein, M. Lauseker, R. Hehlmann, S. Saussele, P. Erben, C. Dietz, A. Fabarius, U. Proetel, S. Schnittger, C. Haferlach, S. W. Krause, J. Schubert, H. Einsele, M. Hanel, J. Dengler, C. Falge, L. Kanz, A. Neubauer, M. Kneba, F. Stegelmann, M. Pfreundschuh, C. F. Waller, K. Spiekermann, G. M. Baerlocher, M. Pfirrmann, J. Hasford, W.-K. Hofmann, A. Hochhaus, M. C. Muller, None None	Haematologica	2014	3	3	3
10.3324/haematol.2014.106468	Hematopoiesis specific loss of Cdk2 and Cdk4 results in increased erythrocyte size and delayed platelet recovery following stress	S. R. Jayapal, C. Q. Wang, X. Bisteau, M. J. Caldez, S. Lim, V. Tergaonkar, M. Osato, P. Kaldis	Haematologica	2015	3	3	2
10.3324/haematol.2014.110155	Induction of adult levels of  -globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XL	K. Trakarnsanga, M. C. Wilson, W. Lau, B. K. Singleton, S. F. Parsons, P. Sakuntanaga, R. Kurita, Y. Nakamura, D. J. Anstee, J. Frayne	Haematologica	2014	3	3	3
10.3324/haematol.2014.112144	In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis	S. Vanhee, K. De Mulder, Y. Van Caeneghem, G. Verstichel, N. Van Roy, B. Menten, I. Velghe, J. Philippe, D. De Bleser, B. N. Lambrecht, T. Taghon, G. Leclercq, T. Kerre, B. Vandekerckhove	Haematologica	2014	4	3	3
10.3324/haematol.2014.113142	The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia	H. L. M. Rajala, T. Olson, M. J. Clemente, S. Lagstrom, P. Ellonen, T. Lundan, D. E. Hamm, S. A. U. Zaman, J. M. Lopez Marti, E. I. Andersson, A. Jerez, K. Porkka, J. P. Maciejewski, T. P. Loughran, S. Mustjoki	Haematologica	2014	8	3	3
10.3324/haematol.2014.113399	Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study)	M. Caira, A. Candoni, L. Verga, A. Busca, M. Delia, A. Nosari, C. Caramatti, C. Castagnola, C. Cattaneo, R. Fanci, A. Chierichini, L. Melillo, M. E. Mitra, M. Picardi, L. Potenza, P. Salutari, N. Vianelli, L. Facchini, M. Cesarini, M. R. De Paolis, R. Di Blasi, F. Farina, A. Venditti, A. Ferrari, M. Garzia, C. Gasbarrino, R. Invernizzi, F. Lessi, A. Manna, B. Martino, G. Nadali, M. Offidani, L. Paris, V. Pavone, G. Rossi, A. Spadea, G. Specchia, E. M. Trecarichi, A. Vacca, S. Cesaro, V. Perriello, F. Aversa, M. Tumbarello, L. Pagano, None None	Haematologica	2015	4	3	2
10.3324/haematol.2014.114595	RAS diseases in children	C. M. Niemeyer	Haematologica	2014	3	3	2
10.3324/haematol.2014.118521	Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble form	A. Pagani, M. Vieillevoye, A. Nai, M. Rausa, M. Ladli, C. Lacombe, P. Mayeux, F. Verdier, C. Camaschella, L. Silvestri	Haematologica	2015	4	3	3
10.3324/haematol.2014.120857	Somatic calreticulin mutations in patients with Budd-Chiari syndrome and portal vein thrombosis	E. P. C. Plompen, P. J. M. Valk, I. Chu, S. D. Murad, A. Plessier, F. Turon, J. Trebicka, M. Primignani, J. C. Garcia-Pagan, D. C. Valla, H. L. A. Janssen, F. W. G. Leebeek, None None	Haematologica	2015	4	3	1
10.3324/haematol.2014.123018	Transcription and methylation analysis of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation	C. Gaillard, T. A. Tokuyasu, G. Rosen, J. Sotzen, A. Vitaliano-Prunier, R. Roy, E. Passegue', H. de The', M. E. Figueroa, S. C. Kogan	Haematologica	2015	3	3	2
10.3324/haematol.2013.085209	Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials	D. A. Pollyea, J. A. Gutman, L. Gore, C. A. Smith, C. T. Jordan	Haematologica	2014	2	2	2
10.3324/haematol.2013.085548	Nature and importance of follicular lymphoma precursors	E. Mamessier, F. Broussais-Guillaumot, B. Chetaille, R. Bouabdallah, L. Xerri, E. S. Jaffe, B. Nadel	Haematologica	2014	2	2	2
10.3324/haematol.2013.087619	Update on treatment of light chain amyloidosis	S. Mahmood, G. Palladini, V. Sanchorawala, A. Wechalekar	Haematologica	2014	2	2	2
10.3324/haematol.2013.087809	Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies	L. Lopez-Corral, L. A. Corchete, M. E. Sarasquete, M. V. Mateos, R. Garcia-Sanz, E. Ferminan, J.-J. Lahuerta, J. Blade, A. Oriol, A. I. Teruel, M. L. Martino, J. Hernandez, J. M. Hernandez-Rivas, F. J. Burguillo, J. F. San Miguel, N. C. Gutierrez	Haematologica	2014	2	2	2
10.3324/haematol.2013.091264	Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder	P. Khoury, J. Herold, A. Alpaugh, E. Dinerman, N. Holland-Thomas, J. Stoddard, S. Gurprasad, I. Maric, O. Simakova, L. B. Schwartz, J. Fong, C.-C. R. Lee, L. Xi, Z. Wang, M. Raffeld, A. D. Klion	Haematologica	2014	2	2	2
10.3324/haematol.2013.091991	Heme and erythropoieis: more than a structural role	D. Chiabrando, S. Mercurio, E. Tolosano	Haematologica	2014	2	2	2
10.3324/haematol.2013.093971	The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease	S. Singbrant, M. Wall, J. Moody, G. Karlsson, A. M. Chalk, B. Liddicoat, M. R. Russell, C. R. Walkley, S. Karlsson	Haematologica	2014	2	2	2
10.3324/haematol.2013.097154	Lactotransferrin-Cre reporter mice trace neutrophils, monocytes/macrophages and distinct subtypes of dendritic cells	B. Kovacic, A. Hoelbl-Kovacic, K. M. Fischhuber, N. R. Leitner, D. Gotthardt, E. Casanova, V. Sexl, M. Muller	Haematologica	2014	2	2	2
10.3324/haematol.2013.098442	Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy	S. Bibi, M. D. Arslanhan, F. Langenfeld, S. Jeanningros, S. Cerny-Reiterer, E. Hadzijusufovic, L. Tchertanov, R. Moriggl, P. Valent, M. Arock	Haematologica	2014	2	2	2
10.3324/haematol.2013.100198	Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT	Y. Chalandon, J. R. Passweg, C. Guglielmi, S. Iacobelli, J. Apperley, N. P. M. Schaap, J. Finke, M. Robin, R. Fedele, D. Bron, I. Yakoub-Agha, A. van Biezen, T. de Witte, N. Kroger, E. Olavarria, None None	Haematologica	2014	2	2	2
10.3324/haematol.2013.101972	Low leukotriene B4 receptor 1 leads to ALOX5 downregulation at diagnosis of chronic myeloid leukemia	C. M. Lucas, R. J. Harris, A. Giannoudis, E. McDonald, R. E. Clark	Haematologica	2014	2	2	2
10.3324/haematol.2013.103218	The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale	A. Gallamini, S. F. Barrington, A. Biggi, S. Chauvie, L. Kostakoglu, M. Gregianin, M. Meignan, G. N. Mikhaeel, A. Loft, J. M. Zaucha, J. F. Seymour, M. S. Hofman, L. Rigacci, A. Pulsoni, M. Coleman, E. J. Dann, L. Trentin, O. Casasnovas, C. Rusconi, P. Brice, S. Bolis, S. Viviani, F. Salvi, S. Luminari, M. Hutchings	Haematologica	2014	2	2	2
10.3324/haematol.2014.105908	Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation	C. Vallejo, M. Batlle, L. Vazquez, C. Solano, A. Sampol, R. Duarte, D. Hernandez, J. Lopez, M. Rovira, S. Jimenez, D. Valcarcel, V. Belloch, M. Jimenez, I. Jarque, None None	Haematologica	2014	2	2	2
10.3324/haematol.2014.107011	Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy	F. D. Roit, P. J. Engelberts, R. P. Taylor, E. C. W. Breij, G. Gritti, A. Rambaldi, M. Introna, P. W. H. I. Parren, F. J. Beurskens, J. Golay	Haematologica	2014	2	2	1
10.3324/haematol.2014.107482	Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations	H. Andrikovics, T. Krahling, K. Balassa, G. Halm, A. Bors, M. Koszarska, A. Batai, J. Dolgos, J. Csomor, M. Egyed, A. Sipos, P. Remenyi, A. Tordai, T. Masszi	Haematologica	2014	2	2	2
10.3324/haematol.2014.107938	Early lymphoid lesions: conceptual, diagnostic and clinical challenges	K. A. Ganapathi, S. Pittaluga, O. O. Odejide, A. S. Freedman, E. S. Jaffe	Haematologica	2014	2	2	2
10.3324/haematol.2014.112813	The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study	A. Maccio, C. Madeddu, G. Gramignano, C. Mulas, L. Tanca, M. C. Cherchi, C. Floris, I. Omoto, A. Barracca, T. Ganz	Haematologica	2014	2	2	2
10.3324/haematol.2014.112821	Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity	J. Oldenburg, S. Lacroix-Desmazes, D. Lillicrap	Haematologica	2015	2	2	2
10.3324/haematol.2014.114587	Elevated hypercoagulability markers in hemoglobin SC disease	M. P. Colella, E. V. de Paula, J. A. Machado-Neto, N. Conran, J. M. Annichino-Bizzacchi, F. F. Costa, S. T. Olalla Saad, F. Traina	Haematologica	2015	2	2	2
10.3324/haematol.2014.115345	Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis	A. Bacigalupo, G. Socie, R. M. Hamladji, M. Aljurf, A. Maschan, S. Kyrcz-Krzemien, A. Cybicka, H. Sengelov, A. Unal, D. Beelen, A. Locasciulli, C. Dufour, J. R. Passweg, R. Oneto, A. Signori, J. C. W. Marsh, None None	Haematologica	2015	3	2	2
10.3324/haematol.2014.115683	The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia	K. Durinck, A. Wallaert, I. Van de Walle, W. Van Loocke, P.-J. Volders, S. Vanhauwaert, E. Geerdens, Y. Benoit, N. Van Roy, B. Poppe, J. Soulier, J. Cools, P. Mestdagh, J. Vandesompele, P. Rondou, P. Van Vlierberghe, T. Taghon, F. Speleman	Haematologica	2014	2	2	2
10.3324/haematol.2014.116269	Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study	A. Gunther, P. Baumann, R. Burger, C. Kellner, W. Klapper, R. Schmidmaier, M. Gramatzki	Haematologica	2015	2	2	2
10.3324/haematol.2014.116855	The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection	L. Arcaini, D. Rossi, M. Lucioni, M. Nicola, A. Bruscaggin, V. Fiaccadori, R. Riboni, A. Ramponi, V. V. Ferretti, S. Cresta, G. M. Casaluci, M. Bonfichi, M. Gotti, M. Merli, A. Maffi, M. Arra, M. Varettoni, S. Rattotti, L. Morello, M. L. Guerrera, R. Sciarra, G. Gaidano, M. Cazzola, M. Paulli	Haematologica	2014	2	2	2
10.3324/haematol.2014.117028	Inhibition of c-Kit by tyrosine kinase inhibitors	A. Galanis, M. Levis	Haematologica	2014	2	2	1
10.3324/haematol.2014.118158	Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a Phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia	C. Moreno, M. Montillo, P. Panayiotidis, M. Dimou, A. Bloor, J. Dupuis, A. Schuh, S. Norin, C. Geisler, P. Hillmen, M. Doubek, M. Trn ny, P. Obrtlikova, L. Laurenti, S. Stilgenbauer, L. Smolej, P. Ghia, F. Cymbalista, U. Jaeger, K. Stamatopoulos, N. Stavroyianni, P. Carrington, H. Zouabi, V. Leblond, J. C. Gomez-Garcia, M. Rubio, R. Marasca, G. Musuraca, L. Rigacci, L. Farina, R. Paolini, S. Pospisilova, E. Kimby, C. Bradley, E. Montserrat	Haematologica	2015	4	2	1
10.3324/haematol.2014.122069	Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B	M. K. Kashyap, D. Kumar, R. Villa, J. J. La Clair, C. Benner, R. Sasik, H. Jones, E. M. Ghia, L. Z. Rassenti, T. J. Kipps, M. D. Burkart, J. E. Castro	Haematologica	2015	2	2	1
10.3324/haematol.2014.122457	Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication	C. C. F. M. J. Baaten, L. F. Veenstra, R. Wetzels, J. P. van Geffen, F. Swieringa, S. M. de Witt, Y. M. C. Henskens, H. Crijns, S. Nylander, J. J. J. van Giezen, J. W. M. Heemskerk, P. E. J. van der Meijden	Haematologica	2015	2	2	2
10.3324/haematol.2015.124164	Evidence of long-term disease control with panobinostat maintenance in patients with relapsed multiple myeloma	E. M. Ocio, J. Davila, J.-C. Caballero, S. Alonso, V. G. de la Calle, R. Garcia-Sanz, L. Gazi, S. Opio, M. Jimenez, J. F. San-Miguel, M.-V. Mateos	Haematologica	2015	2	2	2
10.3324/haematol.2015.124693	Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG)	P. Cramer, S. Isfort, J. Bahlo, S. Stilgenbauer, H. Dohner, M. Bergmann, M. Stauch, M. Kneba, E. Lange, P. Langerbeins, N. Pflug, G. Kovacs, V. Goede, A.-M. Fink, T. Elter, K. Fischer, C.-M. Wendtner, M. Hallek, B. Eichhorst	Haematologica	2015	2	2	2
10.3324/haematol.2015.125492	CD14+ cells from peripheral blood positively regulate hematopoietic stem and progenitor cell survival resulting in increased erythroid yield	E. Heideveld, F. Masiello, M. Marra, F. Esteghamat, N. Ya c, M. von Lindern, A. R. F. Migliaccio, E. van den Akker	Haematologica	2015	2	2	2
10.3324/haematol.2015.125864	Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma	J. F. San Miguel, K. C. Weisel, K. W. Song, M. Delforge, L. Karlin, H. Goldschmidt, P. Moreau, A. Banos, A. Oriol, L. Garderet, M. Cavo, V. Ivanova, A. Alegre, J. Martinez-Lopez, C. Chen, C. Renner, N. J. Bahlis, X. Yu, T. Teasdale, L. Sternas, C. Jacques, M. H. Zaki, M. A. Dimopoulos	Haematologica	2015	2	2	2
10.3324/haematol.2015.126821	Ruxolitinib in combination with Lenalidomide as therapy for patients with myelofibrosis	N. Daver, J. Cortes, K. Newberry, E. Jabbour, L. Zhou, X. Wang, S. Pierce, T. Kadia, K. Sasaki, G. Borthakur, F. Ravandi, N. Pemmaraju, H. Kantarjian, S. Verstovsek	Haematologica	2015	2	2	2
10.3324/haematol.2015.127373	Transplantation of Macaca cynomolgus iPS-derived hematopoietic cells in NSG immunodeficient mice	S. Abed, A. Tubsuwan, P. Chaichompoo, I. H. Park, A. Pailleret, A. Benyoucef, L. Tosca, E. De Dreuzy, A. Paulard, M. Granger-Locatelli, F. Relouzat, S. Prost, G. Tachdjian, S. Fucharoen, G. Q. Daley, E. Payen, S. Chretien, P. Leboulch, L. Maouche-Chretien	Haematologica	2015	2	2	1
10.3324/haematol.2015.129601	Impact of red cell distribution width on future risk of cancer and all-cause mortality among cancer patients - the Tromso Study	T. S. Ellingsen, J. Lappegard, T. Skjelbakken, S. K. Braekkan, J.-B. Hansen	Haematologica	2015	2	2	1
10.3324/haematol.2015.129692	Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation	J. B. Kunz, T. Rausch, O. R. Bandapalli, J. Eilers, P. Pechanska, S. Schuessele, Y. Assenov, A. M. Stutz, R. Kirschner-Schwabe, J. Hof, C. Eckert, A. von Stackelberg, M. Schrappe, M. Stanulla, R. Koehler, S. Avigad, S. Elitzur, R. Handgretinger, V. Benes, J. Weischenfeldt, J. O. Korbel, M. U. Muckenthaler, A. E. Kulozik	Haematologica	2015	2	2	2
10.3324/haematol.2015.131573	Deficiency of the ribosome biogenesis gene Sbds in hematopoietic stem and progenitor cells causes neutropenia in mice by attenuating lineage progression in myelocytes	N. A. Zambetti, E. M. J. Bindels, P. M. H. Van Strien, M. G. Valkhof, M. N. Adisty, R. M. Hoogenboezem, M. A. Sanders, J. M. Rommens, I. P. Touw, M. H. G. P. Raaijmakers	Haematologica	2015	2	2	1
10.3324/haematol.2015.132530	Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia	A. Narita, H. Muramatsu, Y. Sekiya, Y. Okuno, H. Sakaguchi, N. Nishio, N. Yoshida, X. Wang, Y. Xu, N. Kawashima, S. Doisaki, A. Hama, Y. Takahashi, K. Kudo, H. Moritake, M. Kobayashi, R. Kobayashi, E. Ito, H. Yabe, S. Ohga, A. Ohara, S. Kojima, None None	Haematologica	2015	2	2	2
10.3324/haematol.2013.085217	Clinical and genetic predictors of prognosis in myelodysplastic syndromes	R. Bejar	Haematologica	2014	1	1	1
10.3324/haematol.2013.087536	Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia	K. Stringaris, T. Sekine, A. Khoder, A. Alsuliman, B. Razzaghi, R. Sargeant, J. Pavlu, G. Brisley, H. de Lavallade, A. Sarvaria, D. Marin, S. Mielke, J. F. Apperley, E. J. Shpall, J. Barrett, K. Rezvani	Haematologica	2014	1	1	1
10.3324/haematol.2013.091165	Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia	H. Sakaguchi, N. Nishio, A. Hama, N. Kawashima, X. Wang, A. Narita, S. Doisaki, Y. Xu, H. Muramatsu, N. Yoshida, Y. Takahashi, K. Kudo, H. Moritake, K. Nakamura, R. Kobayashi, E. Ito, H. Yabe, S. Ohga, A. Ohara, S. Kojima, None None	Haematologica	2014	1	1	1
10.3324/haematol.2013.092684	Primary thrombocytosis in children	N. Kucine, K. M. Chastain, M. B. Mahler, J. B. Bussel	Haematologica	2014	1	1	1
10.3324/haematol.2013.093161	Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry	H. Schrezenmeier, P. Muus, G. Socie, J. Szer, A. Urbano-Ispizua, J. P. Maciejewski, R. A. Brodsky, M. Bessler, Y. Kanakura, W. Rosse, G. Khursigara, C. Bedrosian, P. Hillmen	Haematologica	2014	1	1	1
10.3324/haematol.2013.096248	B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies	J. P. Vaque, N. Martinez, A. Batlle-Lopez, C. Perez, S. Montes-Moreno, M. Sanchez-Beato, M. A. Piris	Haematologica	2014	1	1	1
10.3324/haematol.2013.096362	Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia	O. Perbellini, E. Falisi, I. Giaretta, E. Boscaro, E. Novella, M. Facco, S. Fortuna, S. Finotto, E. Amati, F. Maniscalco, A. Montaldi, A. Alghisi, F. Aprili, L. Bonaldi, R. Paolini, M. T. Scupoli, L. Trentin, A. Ambrosetti, G. Semenzato, G. Pizzolo, F. Rodeghiero, C. Visco	Haematologica	2014	1	1	1
10.3324/haematol.2013.096669	A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis	C. L. Andersen, N. B. Mortensen, T. W. Klausen, H. Vestergaard, O. W. Bjerrum, H. C. Hasselbalch	Haematologica	2014	1	1	1
10.3324/haematol.2013.096859	The importance of calcium in the regulation of megakaryocyte function	C. Andrea Di Buduo, F. Moccia, M. Battiston, L. De Marco, M. Mazzucato, R. Moratti, F. Tanzi, A. Balduini	Haematologica	2014	1	1	1
10.3324/haematol.2013.098517	t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients	J. D. Sandahl, E. A. Coenen, E. Forestier, J. Harbott, B. Johansson, G. Kerndrup, S. Adachi, A. Auvrignon, H. B. Beverloo, J.-M. Cayuela, L. Chilton, M. Fornerod, V. de Haas, C. J. Harrison, H. Inaba, G. J. L. Kaspers, D.-C. Liang, F. Locatelli, R. Masetti, C. Perot, S. C. Raimondi, K. Reinhardt, D. Tomizawa, N. von Neuhoff, M. Zecca, C. M. Zwaan, M. M. van den Heuvel-Eibrink, H. Hasle	Haematologica	2014	1	1	1
10.3324/haematol.2013.098657	Knockdown of Hnrnpa0, a del(5q) gene, alters myeloid cell fate in murine cells through regulation of AU-rich transcripts	D. J. Young, A. Stoddart, J. Nakitandwe, S.-C. Chen, Z. Qian, J. R. Downing, M. M. Le Beau	Haematologica	2014	1	1	1
10.3324/haematol.2013.098913	Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders	A. Henriques, A. Rodriguez-Caballero, I. Criado, A. W. Langerak, W. G. Nieto, Q. Lecrevisse, M. Gonzalez, E. Cortesao, A. Paiva, J. Almeida, A. Orfao	Haematologica	2014	1	1	1
10.3324/haematol.2013.098954	Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia	A. Talbot, R. P. de Latour, E. Raffoux, N. Buchbinder, S. Vigouroux, N. Milpied, T. Leblanc, J. Soulier, M. Michallet, G. Socie	Haematologica	2014	1	1	1
10.3324/haematol.2013.099796	The prognostic impact of minimal residual disease in patients with chronic lymphocytic leukemia requiring first-line therapy	R. Santacruz, N. Villamor, M. Aymerich, A. Martinez-Trillos, C. Lopez, A. Navarro, M. Rozman, S. Bea, C. Royo, M. Cazorla, D. Colomer, E. Gine, M. Pinyol, X. S. Puente, C. Lopez-Otin, E. Campo, A. Lopez-Guillermo, J. Delgado	Haematologica	2014	1	1	1
10.3324/haematol.2013.100073	Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab	P. Schlegel, P. Lang, G. Zugmaier, M. Ebinger, H. Kreyenberg, K.-E. Witte, J. Feucht, M. Pfeiffer, H.-M. Teltschik, C. Kyzirakos, T. Feuchtinger, R. Handgretinger	Haematologica	2014	1	1	1
10.3324/haematol.2013.100784	Survival analysis in hematologic malignancies: recommendations for clinicians	J. Delgado, A. Pereira, N. Villamor, A. Lopez-Guillermo, C. Rozman	Haematologica	2014	1	1	0
10.3324/haematol.2013.100982	Bortezomib just for induction or also for maintenance in myeloma patients with renal impairment?	J. F. San Miguel	Haematologica	2014	1	1	1
10.3324/haematol.2013.101725	DDX3X-MLLT10 fusion in adults with NOTCH1 positive T-cell acute lymphoblastic leukemia	L. Brandimarte, R. La Starza, V. Gianfelici, G. Barba, V. Pierini, D. Di Giacomo, J. Cools, L. Elia, A. Vitale, L. Luciano, A. Bardi, S. Chiaretti, C. Matteucci, G. Specchia, C. Mecucci	Haematologica	2014	1	1	1
10.3324/haematol.2013.102327	Connective tissue growth factor is expressed in bone marrow stromal cells and promotes interleukin-7-dependent B lymphopoiesis	L. C. Cheung, D. H. Strickland, M. Howlett, J. Ford, A. K. Charles, K. M. Lyons, D. R. Brigstock, R. Goldschmeding, C. H. Cole, W. S. Alexander, U. R. Kees	Haematologica	2014	1	1	1
10.3324/haematol.2013.102897	Severe platelet desialylation in a patient with glycoprotein Ib/IX antibody-mediated immune thrombocytopenia and fatal pulmonary hemorrhage	J. Li, J. L. Callum, Y. Lin, Y. Zhou, G. Zhu, H. Ni	Haematologica	2014	1	1	1
10.3324/haematol.2013.103143	The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice	A. Nai, R. M. Pellegrino, M. Rausa, A. Pagani, M. Boero, L. Silvestri, G. Saglio, A. Roetto, C. Camaschella	Haematologica	2014	1	1	1
10.3324/haematol.2014.104075	Early onset hypercholesterolemia induced by the 2nd-generation tyrosine kinase inhibitor nilotinib in patients with chronic phase-chronic myeloid leukemia	D. Rea, T. Mirault, T. Cluzeau, J.-F. Gautier, F. Guilhot, H. Dombret, E. Messas	Haematologica	2014	1	1	1
10.3324/haematol.2014.104166	Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation	K. Murase, H. T. Kim, O. R. G. Bascug, Y. Kawano, J. Ryan, K.-i. Matsuoka, M. S. Davids, J. Koreth, V. T. Ho, C. Cutler, P. Armand, E. P. Alyea, B. R. Blazar, J. H. Antin, R. J. Soiffer, A. Letai, J. Ritz	Haematologica	2014	2	1	1
10.3324/haematol.2014.104224	Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology	D. De Rocco, R. Bottega, E. Cappelli, S. Cavani, M. Criscuolo, E. Nicchia, F. Corsolini, C. Greco, A. Borriello, J. Svahn, M. Pillon, C. Mecucci, G. Casazza, F. Verzegnassi, C. Cugno, A. Locasciulli, P. Farruggia, D. Longoni, U. Ramenghi, W. Barberi, F. Tucci, S. Perrotta, P. Grammatico, H. Hanenberg, F. Della Ragione, C. Dufour, A. Savoia, None None	Haematologica	2014	1	1	1
10.3324/haematol.2014.104711	Frequent occurrence of non-malignant genetic alterations in clinical grade mesenchymal stromal cells expanded for cell therapy protocols	C. Capelli, O. Pedrini, G. Cassina, O. Spinelli, S. Salmoiraghi, J. Golay, A. Rambaldi, U. Giussani, M. Introna	Haematologica	2014	1	1	1
10.3324/haematol.2014.106088	The truncated RUNX1/ETO activates VLA-4-dependent adhesion and migration of hematopoietic progenitor cells	K. Ponnusamy, L. Chen-Wichmann, O. N. Kuvardina, J. Lausen, R. Henschler, C. Wichmann	Haematologica	2014	1	1	1
10.3324/haematol.2014.106096	Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation	C. Dufour, M. Pillon, J. Passweg, G. Socie, A. Bacigalupo, G. Franceschetto, E. Carraro, R. Oneto, A. M. Risitano, R. P. de Latour, A. Tichelli, A. Rovo, C. Peters, B. Hoechsmann, S. Samarasinghe, A. G. Kulasekararaj, H. Schrezenmeier, M. Aljurf, J. Marsh	Haematologica	2014	1	1	1
10.3324/haematol.2014.106401	Critical role of SHP2 (PTPN11) signaling in germinal center-derived lymphoma	X. Jiang, H. Guo, J. Wu, Q. He, Y. Li, M. Wang, H. Pan, W. Li, J. Wang, Q. Wang, J. Shen, Y. Ke, R. Zhou	Haematologica	2014	1	1	1
10.3324/haematol.2014.107714	Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients	C. Blimark, E. Holmberg, U.-H. Mellqvist, O. Landgren, M. Bjorkholm, M. Hultcrantz, C. Kjellander, I. Turesson, S. Y. Kristinsson	Haematologica	2014	1	1	1
10.3324/haematol.2014.108530	Markedly perturbed hematopoiesis in acid ceramidase deficient mice	S. Dworski, A. Berger, C. Furlonger, J. M. Moreau, M. Yoshimitsu, J. Trentadue, B. C. Y. Au, C. J. Paige, J. A. Medin	Haematologica	2015	1	1	1
10.3324/haematol.2014.109421	The novel  2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells	M. Kraus, J. Bader, P. P. Geurink, E. S. Weyburne, A. C. Mirabella, T. Silzle, T. B. Shabaneh, W. A. van der Linden, G. de Bruin, S. R. Haile, E. van Rooden, C. Appenzeller, N. Li, A. F. Kisselev, H. Overkleeft, C. Driessen	Haematologica	2015	1	1	1
10.3324/haematol.2014.109769	Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome	Y. Zhao, D. Wu, C. Fei, J. Guo, S. Gu, Y. Zhu, F. Xu, Z. Zhang, L. Wu, X. Li, C. Chang	Haematologica	2014	1	1	1
10.3324/haematol.2014.109801	Identification of minor histocompatibility antigens based on the 1000 Genomes Project	R. Oostvogels, H. M. Lokhorst, M. C. Minnema, M. van Elk, K. van den Oudenalder, E. Spierings, T. Mutis, R. M. Spaapen	Haematologica	2014	1	1	1
10.3324/haematol.2014.109843	Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer	C. Becattini, F. Rondelli, M. C. Vedovati, G. Camporese, M. Giustozzi, M. Boncompagni, S. Pucciarelli, R. Balzarotti, E. Mariani, E. Filippucci, A. Donini, G. Agnelli	Haematologica	2014	1	1	1
10.3324/haematol.2014.109967	Anemia in the elderly: clinical implications and new therapeutic concepts	R. Stauder, S. L. Thein	Haematologica	2014	1	1	1
